Carter Todd Alfred, Chief Scientific Officer of Voyager Therapeutics ($VYGR), sold company shares on the open market three times over the past year for a total of about $40,600. His most recent insider sale occurred on February 24, 2026. These Voyager Therapeutics stock sales rank 10,589th among 11,678 individual insiders, well below the average sale value of 8.6 million and 6.4 transactions per insider. Carter Todd Alfred reported no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 4174 | $3.76 | 145,718.0000 | 58,803,015 | 2.78% | 0.01% |
| Feb. 18, 2026 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 3301 | $3.44 | 149,892.0000 | 58,803,015 | 2.15% | 0.01% |
| Feb. 10, 2026 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 3525 | $3.85 | 153,193.0000 | 58,803,015 | 2.25% | 0.01% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Stock Option (Right to Buy) | 154000 | $0.00 | 154,000.0000 | 58,803,015 | 9999.99% | 0.26% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Common Stock | 33000 | $0.00 | 156,718.0000 | 58,803,015 | 26.67% | 0.06% |
| Feb. 20, 2025 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 3305 | $4.26 | 77,718.0000 | 57,667,543 | 4.08% | 0.01% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Common Stock | 46000 | $0.00 | 123,718.0000 | 57,667,543 | 59.19% | 0.08% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Stock Option (Right to Buy) | 92000 | $0.00 | 92,000.0000 | 57,667,543 | 9999.99% | 0.16% |
| Feb. 11, 2025 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 5413 | $4.45 | 81,023.0000 | 57,667,543 | 6.26% | 0.01% |
| Jan. 14, 2025 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 1191 | $5.13 | 86,436.0000 | 57,667,543 | 1.36% | 0.00% |
| Feb. 21, 2024 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 3365 | $7.47 | 87,627.0000 | 44,569,334 | 3.70% | 0.01% |
| Feb. 20, 2024 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 602 | $7.68 | 90,992.0000 | 44,569,334 | 0.66% | 0.00% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Stock Option (Right to Buy) | 77000 | $0.00 | 77,000.0000 | 44,569,334 | 9999.99% | 0.17% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Common Stock | 38500 | $0.00 | 91,594.0000 | 44,569,334 | 72.51% | 0.09% |
| Jan. 17, 2024 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 1266 | $7.18 | 53,094.0000 | 44,569,334 | 2.33% | 0.00% |
| Sept. 15, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 10500 | $8.16 | 54,360.0000 | 43,520,137 | 16.19% | 0.02% |
| Sept. 15, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 40,000.0000 | 43,520,137 | 11.11% | 0.01% |
| Sept. 15, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | M | Common Stock | 5000 | $2.85 | 64,860.0000 | 43,520,137 | 8.35% | 0.01% |
| July 6, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 5500 | $10.80 | 59,860.0000 | 43,520,137 | 8.41% | 0.01% |
| June 30, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | M | Common Stock | 5000 | $2.85 | 70,360.0000 | 42,161,326 | 7.65% | 0.01% |
| June 30, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 5000 | $11.41 | 65,360.0000 | 42,161,326 | 7.11% | 0.01% |
| June 30, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 45,000.0000 | 42,161,326 | 10.00% | 0.01% |
| March 20, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 2193 | $7.76 | 65,360.0000 | 38,356,810 | 3.25% | 0.01% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Stock Option (Right to Buy) | 68000 | $0.00 | 68,000.0000 | 38,356,810 | 9999.99% | 0.18% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Common Stock | 34000 | $0.00 | 68,291.0000 | 38,356,810 | 99.15% | 0.09% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 738 | $7.45 | 67,553.0000 | 38,356,810 | 1.08% | 0.00% |
| Feb. 13, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 797 | $7.67 | 34,291.0000 | 38,356,810 | 2.27% | 0.00% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 706 | $9.57 | 35,488.0000 | 38,356,810 | 1.95% | 0.00% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 400 | $10.34 | 35,088.0000 | 38,356,810 | 1.13% | 0.00% |
| Jan. 6, 2023 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | S | Common Stock | 388 | $6.41 | 36,194.0000 | 38,356,810 | 1.06% | 0.00% |
| Dec. 31, 2022 | Voyager Therapeutics, Inc. | $VYGR | Carter Todd Alfred | Chief Scientific Officer | A | Common Stock | 388 | $5.17 | 36,582.0000 | 39,570,394 | 1.07% | 0.00% |